DiaMedica Therapeutics, Inc. (DMAC)
7.26
+0.41
(+5.99%)
USD |
NASDAQ |
Sep 21, 16:00
7.26
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Price to Book Value : 10.21 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 9.635 |
| September 17, 2026 | 9.635 |
| September 16, 2026 | 9.326 |
| September 15, 2026 | 9.185 |
| September 14, 2026 | 9.213 |
| September 11, 2026 | 9.101 |
| September 10, 2026 | 9.101 |
| September 09, 2026 | 9.269 |
| September 08, 2026 | 9.199 |
| September 04, 2026 | 9.494 |
| September 03, 2026 | 9.227 |
| September 02, 2026 | 9.494 |
| September 01, 2026 | 9.072 |
| August 31, 2026 | 8.932 |
| August 28, 2026 | 8.988 |
| August 27, 2026 | 9.494 |
| August 26, 2026 | 9.424 |
| August 25, 2026 | 9.480 |
| August 24, 2026 | 9.171 |
| August 21, 2026 | 9.171 |
| August 20, 2026 | 9.171 |
| August 19, 2026 | 9.579 |
| August 18, 2026 | 9.298 |
| August 17, 2026 | 9.312 |
| August 14, 2026 | 9.396 |
| Date | Value |
|---|---|
| August 13, 2026 | 9.494 |
| August 12, 2026 | 9.621 |
| August 11, 2026 | 9.663 |
| August 10, 2026 | 9.354 |
| August 07, 2026 | 9.494 |
| August 06, 2026 | 9.523 |
| August 05, 2026 | 9.375 |
| August 04, 2026 | 9.199 |
| August 03, 2026 | 9.171 |
| July 31, 2026 | 8.918 |
| July 30, 2026 | 9.157 |
| July 29, 2026 | 8.890 |
| July 28, 2026 | 9.340 |
| July 27, 2026 | 9.480 |
| July 24, 2026 | 9.473 |
| July 23, 2026 | 9.593 |
| July 22, 2026 | 9.755 |
| July 21, 2026 | 9.959 |
| July 20, 2026 | 9.860 |
| July 17, 2026 | 10.27 |
| July 16, 2026 | 10.03 |
| July 15, 2026 | 10.75 |
| July 14, 2026 | 10.45 |
| July 13, 2026 | 10.54 |
| July 10, 2026 | 10.79 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.477 |
| Alnylam Pharmaceuticals, Inc. | 24.12 |
| Anika Therapeutics, Inc. | 2.020 |
| Savara, Inc. | 7.799 |
| Vericel Corp. | 5.466 |
Price to Book Value Related Metrics
| PEG Ratio | -2.962 |
| Price | 7.26 |
| Earnings Yield | -9.83% |
| Market Cap | 391.50M |
| PEGY Ratio | -2.962 |